PEG-modified GoldMag nanoparticles (PGMNs) combined with the magnetic field for local drug delivery

Journal of Drug Targeting

Volumn 19, Issue 3, 2011, Pages 161-170

  Chao, Xu ^a   Guo, Lili ^b   Zhao, Yingyong ^a   Hua, Kai ^a   Peng, Mingli ^b   Chen, Chao ^a,b   Cui, Yali ^a,b  

^a NORTHWEST UNIVERSITY   (China)

^b National Engineering Research Center for Miniaturized Detection System   (China)

Author keywords

biodistribution; doxorubicin; drug delivery; PEG modified GoldMag nanoparticles; permanent magnetic field

Indexed keywords

DOXORUBICIN; GOLD NANOPARTICLE; IRON; MACROGOL; MAGNETIC NANOPARTICLE;

ANIMAL CELL; ANIMAL EXPERIMENT; ARTICLE; CELL VIABILITY; CONTROLLED DRUG RELEASE; CONTROLLED STUDY; CYTOTOXICITY; DRUG DELIVERY SYSTEM; DRUG DISTRIBUTION; DRUG LIVER LEVEL; DRUG RELEASE; DRUG TARGETING; HISTOPATHOLOGY; HUMAN; HUMAN CELL; MAGNETIC FIELD; MOUSE; NONHUMAN; PARTICLE SIZE; PRIORITY JOURNAL; RAT; SUSTAINED DRUG RELEASE;

ANIMALS; ANTIBIOTICS, ANTINEOPLASTIC; DELAYED-ACTION PREPARATIONS; DOXORUBICIN; DRUG CARRIERS; DRUG DELIVERY SYSTEMS; DRUG SCREENING ASSAYS, ANTITUMOR; HEP G2 CELLS; HUMANS; IRON; MAGNETICS; METAL NANOPARTICLES; MOLECULAR TARGETED THERAPY; POLYETHYLENE GLYCOLS; RATS; RATS, SPRAGUE-DAWLEY; TISSUE DISTRIBUTION;

EID: 79952669611     PISSN: 1061186X     EISSN: 10292330     Source Type: Journal    
DOI: 10.3109/10611861003801842     Document Type: Article

References (35)

1. Alexiou C, Arnold W, Klein RJ, Parak FG, Hulin P, Bergemann C, Erhardt W, Wagenpfeil S, Lübbe AS. (2000). Locoregional cancer treatment with magnetic drug targeting. Cancer Res, 60, 6641-6648.
2. Alexiou C, Jurgons R, Schmid R, Hilpert A, Bergemann C, Parak F, Iro H. (2005). In vitro and in vivo investigations of targeted chemotherapy with magnetic nanoparticles. J Magn Magn Mater, 293, 389-393. (Pubitemid 40608956)
3. Bergen JM, von Recum HA, Goodman TT, Massey AP, Pun SH. (2006). Gold nanoparticles as a versatile platform for optimizing physicochemical parameters for targeted drug delivery. Macromol Biosci, 6, 506-516. (Pubitemid 44105947)
4. 4/Au core/shell super-paramagnetic microsphere. Sci China Ser B, 44, 404-410. (Pubitemid 32897622)
5. Dobson J. (2006). Magnetic nanoparticles for drug delivery. Drug Dev, 67, 55-60. (Pubitemid 43765049)
6. El-Sayed IH, Huang X, El-Sayed MA. (2005). Surface plasmon resonance scattering and absorption of anti-EGFR antibody conjugated gold nanoparticles in cancer diagnostics: applications in oral cancer. Nano Lett, 5, 829-834. (Pubitemid 40749040)
7. Gbadamosi JK, Hunter AC, Moghimi SM. (2002). PEGylation of microspheres generates a heterogeneous population of particles with diferential surface characteristics and biological performance. FEBS Lett, 532, 338-344. (Pubitemid 35441370)
8. Gupta AK, Curtis AS. (2004). Surface modifed superparamagnetic nanoparticles for drug delivery: interaction studies with human fbroblasts in culture. J Mater Sci Mater Med, 15, 493-496. (Pubitemid 39012168)
9. Gupta AK, Wells S. (2004). Surface-modifed superparamagnetic nanoparticles for drug delivery: preparation, characterization, and cytotoxicity studies. IEEE Trans Nanobioscience, 3, 66-73.
10. Gupta AK, Gupta M. (2005). Cytotoxicity suppression and cellular uptake enhancement of surface modifed magnetic nanoparticles. Biomaterials, 26, 1565-1573. (Pubitemid 39441388)
11. Gupta AK, Gupta M. (2005). Synthesis and surface engineering of iron oxide nanoparticles for biomedical applications. Biomaterials, 26, 3995-4021. (Pubitemid 40044762)
12. Kalambur ZS, Han B, Hammer BE, Shield TW, Bischof JC. (2005). In vitro characterization of movement, heating and visualization of magnetic nanoparticles for biomedical applications. Nanotechnology, 16, 1221-1233. (Pubitemid 40878628)
13. Kinoshita T, Seinoa S, Okitsu K, Nakayama T, Nakagawa T, Yamamoto TA. (2003). Magnetic evaluation of nanostructure of gold-iron composite particles synthesized by a reverse micelle method. J Alloy Compd, 359, 46-50.
14. Kim D, Park S, Lee JH, Jeong YY, Jon S. (2007). Antibiofouling polymer-coated gold nanoparticles as a contrast agent for in vivo X-ray computed tomography imaging. J Am Chem Soc, 129, 7661-7665. (Pubitemid 46981930)
15. Landfester K, Ramirez LP. (2003). Encapsulated magnetite particles for biomedical application. J Phys: Condens Matter, 15, 1345-1361.
16. Lin J, Zhou WL, Kumbhar A, Wiemann J, Fang JY, Carpenter EE, O'Connor CJ. (2001). Gold-coated iron (Fe@Au) nanoparticles: synthesis, characterization, and magnetic feld-induced self-assembly. J Solid State Chem, 159, 26-31. (Pubitemid 32912591)
17. Liu SQ, Tong YW, Yang YY. (2005). Incorporation and in vitro release of doxorubicin in thermally sensitive micelles made from poly (N- isopropylacrylamide-co-N, N-dimethylacrylamide)-b-poly (D, L-lactide-co- glycolide) with varying compositions. Biomaterials, 26, 5064-5074. (Pubitemid 40354239)
18. Loo C, Lin A, Hirsch L, Lee MH, Barton J, Halas N, West J, Drezek R. (2004). Nanoshell-enabled photonics-based imaging and therapy of cancer. Technol Cancer Res Treat, 3, 33-40. (Pubitemid 38250466)
19. Lübbe AS, Bergemann C, Huhnt W, Fricke T, Riess H, Brock JW, Huhn D. (1996). Preclinical experiences with magnetic drug targeting: tolerance and efcacy. Cancer Res, 56, 4694-4701. (Pubitemid 26338072)
20. Maeda H. (2001). Te enhanced permeability and retention (EPR) efect in tumor vasculature: the key role of tumor-selective macromolecular drug targeting. Adv Enzyme Regul, 41, 189-207.
21. Miyamoto D, Oishi M, Kojima K, Yoshimoto K, Nagasaki Y. (2008). Completely dispersible PEGylated gold nanoparticles under physiological conditions: modifcation of gold nanoparticles with precisely controlled PEG-b-polyamine. Langmuir, 24, 5010-5017. (Pubitemid 351725192)
22. Niidome T, Yamagata M, Okamoto Y, Akiyama Y, Takahashi H, Kawano T, Katayama Y, Niidome Y. (2006). PEG-modifed gold nanorods with a stealth character for in vivo applications. J Control Release, 114, 343-347. (Pubitemid 44310822)
23. Pacheco RF, Marquina C, Valdiviaa JG, Gutièrrez M, Romero MS, Cornudella R, Laborda A, Viloria A, Higuera T, García A, Jalón JA, Ibarra MR. (2007). Magnetic nanoparticles for local drug delivery using magnetic implants. J Magn Magn Mater, 311, 318-322. (Pubitemid 46400994)
24. Paciotti GF, Myer L, Weinreich D, Goia D, Pavel N, McLaughlin RE, Tamarkin L. (2004). Colloidal gold: a novel nanoparticle vector for tumor directed drug delivery. Drug Deliv, 11, 169-183. (Pubitemid 38720414)
25. Pankhurst QA, Connolly J, Jones SK. (2003). Applications of magnetic nanoparticles in biomedicine. J Phys D: Appl Phys, 36, 167-181.
26. Park HY, Schadt MJ, Wang L, Lim II, Njoki PN, Kim SH, Jang MY, Luo J, Zhong CJ. (2007). Fabrication of magnetic core@shell Fe oxide@ Au nanoparticles for interfacial bioactivity and bio-separation. Langmuir, 23, 9050-9056. (Pubitemid 47294323)
27. Schwartzberg AM, Olson TY, Talley CE, Zhang JZ. (2006a). Synthesis, characterization, and tunable optical properties of hollow gold nanospheres. J Phys Chem B, 110, 19935-19944. (Pubitemid 44626355)
28. Schwartzberg AM, Oshiro TY, Zhang JZ, Huser T, Talley CE. (2006b). Improving nanoprobes using surface-enhanced Raman scattering from 30-nm hollow gold particles. Anal Chem, 78, 4732-4736.
29. Sokolov K, Follen M, Aaron J, Pavlova I, Malpica A, Lotan R, Richards-Kortum R. (2003). Real-time vital optical imaging of precancer using anti-epidermal growth factor receptor antibodies conjugated to gold nanoparticles. Cancer Res, 63, 1999-2004. (Pubitemid 36538596)
30. Storm G, Belliot SO, Daemen T, Lasic DD. (1995). Surface modifcation of nanoparticles to oppose uptake by the mononuclear phagocyte system. Adv Drug Del Rev, 17, 31-48.
31. Sun C, Lee JH, Zhang MQ. (2008). Magnetic nanoparticles in MR imaging and drug delivery. Adv Drug Deliv Rev, 60, 1252-1265.
32. Yang XY, Zhang XY, Liu ZF, Ma YF, Huang Y, Chen YS. (2008). High-efciency loading and controlled release of doxorubicin hydrochloride on graphene oxide. J Phys Chem C, 112, 17554-17558.
33. Widder KJ, Morris RM, Poore GA, Howard DP, Senyei AE. (1983). Selective targeting of magnetic albumin microspheres containing low-dose doxorubicin: total remission in Yoshida sarcoma-bearing rats. Eur J Cancer Clin Oncol, 19, 135-139. (Pubitemid 13138726)
34. Widder KJ, Senyel AE, Scarpelli GD. (1978). Magnetic microspheres: a model system of site specifc drug delivery in vivo. Proc Soc Exp Biol Med, 158, 141-146. (Pubitemid 8386575)
35. Zhang Y, Kohler N, Zhang M. (2002). Surface modifcation of superparamagnetic magnetite nanoparticles and their intracellular uptake. Biomaterials, 23, 1553-1561. (Pubitemid 34158578)